
|Articles|May 4, 2020
COVID-19: Navigating Remdesivir Results & Institutional Inertia
Author(s)Contagion® Editorial Staff
Cornelius J. Clancy, MD, discusses navigating partial trial information and the need for coherent national coordination on the COVID-19 response.
Advertisement
Segment Description: Cornelius J. Clancy, MD, discusses navigating partial trial information and the need for coherent national coordination on the COVID-19 response.
Advertisement
Advertisement
Advertisement
Trending on Contagion Live
1
Hackensack Meridian Health Joins Phase 3 Trial of Pfizer’s Investigational C difficile Vaccine
2
Initiatives Look to Strengthen Vaccine Policy and Governance in US
3
Lenacapavir and the Future of HIV Prevention: PURPOSE Trials, Long-Acting PrEP, and What Comes Next
4
European Commission Approves Glecaprevir/Pibrentasvir for Hepatitis C
5






















































































































































































































